Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp33803_8k.htm |
| EX-99.2 - EXHIBIT 99.2 - Shire plc | dp33803_ex9902.htm |
Exhibit 99.01
|
Press Release
|
 |
|
www.shire.com
|
|
|
|
Share buyback commenced
Dublin, Ireland – October 26, 2012 – Shire plc (LSE: SHP, NASDAQ: SHPG), confirms that the Company has now commenced its share buyback programme following its announcement on October 25, 2012 as part of its Quarterly results.
For further information please contact:
|
Investor Relations
|
||
|
Eric Rojas
|
erojas@shire.com
|
+1 781 482 0999
|
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
|
Media
|
||
|
Jessica Mann
|
jmann@shire.com
|
+44 1256 894 280
|
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
|
·
|
Behavioral Health and Gastro Intestinal conditions
|
|
·
|
Rare Diseases
|
|
·
|
Regenerative Medicine
|
as well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX